PL3412660T3 - Pochodna sulfonamidowa i zawierająca ją kompozycja farmaceutyczna - Google Patents
Pochodna sulfonamidowa i zawierająca ją kompozycja farmaceutycznaInfo
- Publication number
- PL3412660T3 PL3412660T3 PL17747622T PL17747622T PL3412660T3 PL 3412660 T3 PL3412660 T3 PL 3412660T3 PL 17747622 T PL17747622 T PL 17747622T PL 17747622 T PL17747622 T PL 17747622T PL 3412660 T3 PL3412660 T3 PL 3412660T3
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- composition containing
- containing same
- sulfonamide derivative
- sulfonamide
- Prior art date
Links
- HFFXLYHRNRKAPM-UHFFFAOYSA-N 2,4,5-trichloro-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C(=CC(Cl)=C(Cl)C=2)Cl)=N1 HFFXLYHRNRKAPM-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016021053 | 2016-02-05 | ||
| EP17747622.3A EP3412660B9 (en) | 2016-02-05 | 2017-02-06 | Sulfonamide derivative and pharmaceutical composition containing same |
| PCT/JP2017/004278 WO2017135472A1 (ja) | 2016-02-05 | 2017-02-06 | スルホンアミド誘導体及びそれを含有する医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3412660T3 true PL3412660T3 (pl) | 2021-04-19 |
Family
ID=59500204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17747622T PL3412660T3 (pl) | 2016-02-05 | 2017-02-06 | Pochodna sulfonamidowa i zawierająca ją kompozycja farmaceutyczna |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10562898B2 (pl) |
| EP (1) | EP3412660B9 (pl) |
| JP (1) | JP6820282B2 (pl) |
| KR (1) | KR102870086B1 (pl) |
| CN (1) | CN108699008B (pl) |
| AU (1) | AU2017214589B2 (pl) |
| CA (1) | CA3013433A1 (pl) |
| DK (1) | DK3412660T3 (pl) |
| EA (1) | EA036432B1 (pl) |
| ES (1) | ES2856125T3 (pl) |
| HU (1) | HUE053354T2 (pl) |
| MX (1) | MX381970B (pl) |
| PL (1) | PL3412660T3 (pl) |
| PT (1) | PT3412660T (pl) |
| TW (1) | TWI730042B (pl) |
| WO (1) | WO2017135472A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1124820B1 (en) | 1998-10-26 | 2004-09-22 | The Research Foundation Of State University Of New York | Lipoic acid derivatives and their use in treatment of disease |
| TWI754702B (zh) * | 2016-12-28 | 2022-02-11 | 德商Ｕｃｂ製藥有限公司 | （氮雜）吲哚－和苯並呋喃－３－磺醯胺類 |
| WO2019147824A1 (en) | 2018-01-26 | 2019-08-01 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor |
| US20230033021A1 (en) | 2018-06-20 | 2023-02-02 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
| CN112996786B (zh) | 2018-10-30 | 2024-08-20 | 吉利德科学公司 | 用于抑制α4β7整合素的化合物 |
| EP3873900B1 (en) | 2018-10-30 | 2025-01-08 | Gilead Sciences, Inc. | Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases |
| JP7189369B2 (ja) | 2018-10-30 | 2022-12-13 | ギリアード サイエンシーズ， インコーポレイテッド | アルファ４β７インテグリンの阻害のための化合物 |
| HUE070112T2 (hu) | 2018-10-30 | 2025-05-28 | Gilead Sciences Inc | 3-(Kinolin-8-il)-1,4-dihidropirido[3,4-d]pirimidin-2,4-dion-származékok mint alpha4beta7 integrin gátlók gyulladásos betegségek kezelésére |
| JP7491996B2 (ja) | 2019-08-14 | 2024-05-28 | ギリアード サイエンシーズ， インコーポレイテッド | α４β７インテグリンの阻害のための化合物 |
| US20230107927A1 (en) | 2020-02-28 | 2023-04-06 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
| MX2024004049A (es) | 2021-10-05 | 2024-04-25 | Ea Pharma Co Ltd | Metodo para producir compuesto o sal farmaceuticamente aceptable del mismo. |
| EP4691468A1 (en) | 2023-04-06 | 2026-02-11 | EA Pharma Co., Ltd. | Pharmaceutical composition for treating inflammatory bowel disease |
| WO2024210196A1 (ja) | 2023-04-06 | 2024-10-10 | Ｅａファーマ株式会社 | スルホンアミド誘導体を含有する自己乳化組成物および自己乳化製剤 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6388084B1 (en) | 1999-12-06 | 2002-05-14 | Hoffmann-La Roche Inc. | 4-pyridinyl-n-acyl-l-phenylalanines |
| RU2270193C2 (ru) | 1999-12-06 | 2006-02-20 | Ф.Хоффманн-Ля Рош Аг | 4-пиридинил-n-ацил-l-фенилаланины |
| AU2001234741A1 (en) | 2000-02-04 | 2001-08-14 | Biogen, Inc. | Integrin antagonists |
| CN1325480C (zh) | 2000-08-18 | 2007-07-11 | 味之素株式会社 | 苯基丙氨酸衍生物 |
| AU2003211560A1 (en) | 2002-02-20 | 2003-09-09 | Ajinomoto Co., Inc. | Novel phenylalanine derivative |
| JP4233353B2 (ja) | 2002-02-27 | 2009-03-04 | 田辺三菱製薬株式会社 | 医薬組成物 |
| PE20050232A1 (es) * | 2003-06-25 | 2005-04-01 | Elan Pharm Inc | Metodo y composiciones para tratar la artritis reumatoide |
| KR20110098980A (ko) | 2003-12-22 | 2011-09-02 | 아지노모토 가부시키가이샤 | 신규한 페닐알라닌 유도체 |
| US20050192279A1 (en) | 2004-02-10 | 2005-09-01 | Kent Barbay | Pyridazinones as antagonists of alpha4 integrins |
| AU2005244751A1 (en) * | 2004-04-16 | 2005-12-01 | Genentech, Inc. | Method for augmenting B cell depletion |
| BRPI0611285A2 (pt) | 2005-05-20 | 2010-08-31 | Elan Pharm Inc | derivados de imidazolona fenilalanina |
| BR112014026409B1 (pt) * | 2012-04-24 | 2022-09-06 | EA Pharma Co., Ltd | Derivado de sulfonamida, composição farmacêutica, e, agente para uso no tratamento ou prevenção de uma doença inflamatória |
| DE102013206014A1 (de) * | 2013-04-05 | 2014-10-09 | Dürr Systems GmbH | Energiewandler-System und Baugruppen hierfür |
| DK3064491T3 (da) * | 2013-10-29 | 2020-03-16 | Ea Pharma Co Ltd | Sulfonamidderivat og medicinsk anvendelse deraf |
-
2017
- 2017-02-06 ES ES17747622T patent/ES2856125T3/es active Active
- 2017-02-06 CN CN201780009898.0A patent/CN108699008B/zh active Active
- 2017-02-06 MX MX2018009459A patent/MX381970B/es unknown
- 2017-02-06 EP EP17747622.3A patent/EP3412660B9/en active Active
- 2017-02-06 TW TW106103847A patent/TWI730042B/zh active
- 2017-02-06 US US16/075,415 patent/US10562898B2/en active Active
- 2017-02-06 PL PL17747622T patent/PL3412660T3/pl unknown
- 2017-02-06 PT PT177476223T patent/PT3412660T/pt unknown
- 2017-02-06 WO PCT/JP2017/004278 patent/WO2017135472A1/ja not_active Ceased
- 2017-02-06 DK DK17747622.3T patent/DK3412660T3/da active
- 2017-02-06 KR KR1020187025805A patent/KR102870086B1/ko active Active
- 2017-02-06 EA EA201891780A patent/EA036432B1/ru not_active IP Right Cessation
- 2017-02-06 AU AU2017214589A patent/AU2017214589B2/en active Active
- 2017-02-06 HU HUE17747622A patent/HUE053354T2/hu unknown
- 2017-02-06 CA CA3013433A patent/CA3013433A1/en active Pending
- 2017-02-06 JP JP2017565026A patent/JP6820282B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20180104758A (ko) | 2018-09-21 |
| EP3412660B1 (en) | 2020-11-18 |
| KR102870086B1 (ko) | 2025-10-16 |
| US10562898B2 (en) | 2020-02-18 |
| PT3412660T (pt) | 2021-01-13 |
| AU2017214589B2 (en) | 2020-09-03 |
| EP3412660A1 (en) | 2018-12-12 |
| DK3412660T3 (da) | 2020-11-30 |
| BR112018015855A2 (pt) | 2018-12-26 |
| JPWO2017135472A1 (ja) | 2018-11-29 |
| EA201891780A1 (ru) | 2019-02-28 |
| EP3412660B9 (en) | 2021-04-14 |
| AU2017214589A1 (en) | 2018-08-16 |
| US20190040059A1 (en) | 2019-02-07 |
| TW201733991A (zh) | 2017-10-01 |
| MX2018009459A (es) | 2018-09-21 |
| CN108699008A (zh) | 2018-10-23 |
| EP3412660A4 (en) | 2019-07-10 |
| JP6820282B2 (ja) | 2021-01-27 |
| ES2856125T3 (es) | 2021-09-27 |
| CN108699008B (zh) | 2021-10-08 |
| WO2017135472A1 (ja) | 2017-08-10 |
| TWI730042B (zh) | 2021-06-11 |
| EA036432B1 (ru) | 2020-11-10 |
| CA3013433A1 (en) | 2017-08-10 |
| HUE053354T2 (hu) | 2021-06-28 |
| MX381970B (es) | 2025-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258082B (en) | History of benzaimidazole and pharmaceutical preparations containing them | |
| IL265260B (en) | pharmaceutical preparations | |
| IL265360B (en) | Pharmaceutical composition | |
| ZA201802125B (en) | Pharmaceutical composition and application thereof | |
| PL3412660T3 (pl) | Pochodna sulfonamidowa i zawierająca ją kompozycja farmaceutyczna | |
| IL269061A (en) | A pharmaceutical preparation containing Selexifag | |
| IL262654A (en) | Pharmacy preparation | |
| SI3426348T1 (sl) | Derivat 3-dezoksi in njegovi farmacevtski sestavki | |
| LT3655017T (lt) | Farmacinė kompozicija | |
| IL265349A (en) | Pharmaceutical composition | |
| IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
| SG11201705543VA (en) | Sulfonamide pharmaceutical composition | |
| IL272419A (en) | Pharmaceutical composition | |
| PL3454838T3 (pl) | Kompozycja farmaceutyczna | |
| GB201615917D0 (en) | Pharmaceutical composition | |
| SG10202106375UA (en) | Pharmaceutical compositions and use thereof | |
| IL257621B (en) | A catechol derivative and a pharmaceutical preparation that includes it | |
| GB201615914D0 (en) | Pharmaceutical composition | |
| GB201615910D0 (en) | Pharmaceutical composition | |
| IL265436B (en) | Pharmacy preparation | |
| PL3424500T3 (pl) | Kompozycja farmaceutyczna zawierająca famitynib | |
| GB201620519D0 (en) | Pharmaceutical composition | |
| ZA201903341B (en) | Pharmaceutical compositions and uses thereof | |
| IL265428A (en) | Pharmaceutical composition | |
| PT3476391T (pt) | Composição farmacêutica que compreende arginina para utilização no tratamento da doença de poliq |